Article
Antidepressant Effects of Aripiprazole Augmentation for Cilostazol-Treated Mice Exposed to Chronic Mild Stress after Ischemic Stroke.
International journal of molecular sciences - 8 Feb 2017
Kim Yu Ri, Kim Ha Neui, Hong Ki Whan, Shin Hwa Kyoung, Choi Byung Tae
Abstract excerpt
The aim of this study was to determine the effects and underlying mechanism of aripiprazole (APZ) augmentation for cilostazol (CLS)-treated post-ischemic stroke mice that were exposed to chronic mild stress (CMS). Compared to treatment with either APZ or CLS alone, the combined treatment resulted in a greater reduction in depressive behaviors, including anhedonia, despair-like behaviors, and memory impairments....
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
